Who
Michael Stephen Tung
EVP & CFO
Company insider
Files Form 4 as: EVP & CFO, vTv Therapeutics.
In numbers
- Trades disclosed
- 3
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 19 May 2025
- Last trade
- 17 Feb 2026
- Last filed
- 18 Feb 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Feb 2026filed 18 Feb 2026 | VTVT vTv Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | $1.7M44,969 at $36.92 | filing |
| 17 Feb 2026filed 18 Feb 2026 | VTVT vTv Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | $1.7M44,969 at $36.92 | filing |
| 19 May 2025filed 21 May 2025 | VTVT vTv Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | $956K45,000 at $21.25 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.